Marshall J C, Harsoulis P, Anderson D C, McNeilly A S, Besser G M, Hall R
Br Med J. 1972 Dec 16;4(5841):643-5. doi: 10.1136/bmj.4.5841.643.
The responses of serum immunoreactive luteinizing hormone (LH) and follicle stimulating hormone (FSH) after intravenous injection of 100 mug of synthetic LH/FSH-RH have been studied in 14 patients with the syndrome of isolated pituitary gonadotrophin deficiency. Nine of the patients showed a rise of both hormones, two a small rise of FSH only, and three were unresponsive. In two of the unresponsive patients injection of a 500-mug dose produced a small rise of LH only. Of the patients who responded, four had LH and FSH responses within the normal adult range, while in the others the responses were smaller and delayed. It is suggested that this syndrome is due to a lack of the hypothalamic-releasing hormone itself, rather than to a pituitary deficiency. However, repeat assessment after prolonged administration of the releasing hormone will be necessary before a pituitary disorder can be excluded in all patients. The synthetic LH/FSH-RH, preferably as a depot preparation, may provide a means of treating these patients to induce the development of puberty and subsequent fertility.
对14例孤立性垂体促性腺激素缺乏综合征患者静脉注射100微克合成促黄体生成素释放激素(LH/FSH-RH)后血清免疫反应性促黄体生成素(LH)和促卵泡生成素(FSH)的反应进行了研究。9例患者两种激素均升高,2例仅FSH有小幅升高,3例无反应。在2例无反应的患者中,注射500微克剂量仅使LH有小幅升高。在有反应的患者中,4例患者的LH和FSH反应在正常成人范围内,而其他患者的反应较小且延迟。提示该综合征是由于下丘脑释放激素本身缺乏,而非垂体缺乏。然而,在排除所有患者的垂体疾病之前,有必要在长期给予释放激素后进行重复评估。合成LH/FSH-RH,最好作为长效制剂,可能为治疗这些患者以诱导青春期发育和随后的生育能力提供一种方法。